

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | behavioral response to nicotine (GO:0035095) | 6.23782097 |
| 2 | kynurenine metabolic process (GO:0070189) | 4.65487415 |
| 3 | indole-containing compound catabolic process (GO:0042436) | 4.47352111 |
| 4 | indolalkylamine catabolic process (GO:0046218) | 4.47352111 |
| 5 | tryptophan catabolic process (GO:0006569) | 4.47352111 |
| 6 | indolalkylamine metabolic process (GO:0006586) | 4.10823133 |
| 7 | fucose catabolic process (GO:0019317) | 4.05094041 |
| 8 | L-fucose metabolic process (GO:0042354) | 4.05094041 |
| 9 | L-fucose catabolic process (GO:0042355) | 4.05094041 |
| 10 | detection of light stimulus involved in visual perception (GO:0050908) | 3.89395074 |
| 11 | detection of light stimulus involved in sensory perception (GO:0050962) | 3.89395074 |
| 12 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 3.72572401 |
| 13 | tryptophan metabolic process (GO:0006568) | 3.61677731 |
| 14 | gamma-aminobutyric acid transport (GO:0015812) | 3.48045404 |
| 15 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.43300959 |
| 16 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 3.43074169 |
| 17 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.40857867 |
| 18 | cellular ketone body metabolic process (GO:0046950) | 3.39873911 |
| 19 | neural tube formation (GO:0001841) | 3.37255106 |
| 20 | nonmotile primary cilium assembly (GO:0035058) | 3.31544279 |
| 21 | cellular biogenic amine catabolic process (GO:0042402) | 3.29492739 |
| 22 | amine catabolic process (GO:0009310) | 3.29492739 |
| 23 | regulation of gene silencing by RNA (GO:0060966) | 3.15931440 |
| 24 | regulation of posttranscriptional gene silencing (GO:0060147) | 3.15931440 |
| 25 | regulation of gene silencing by miRNA (GO:0060964) | 3.15931440 |
| 26 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.10785083 |
| 27 | indole-containing compound metabolic process (GO:0042430) | 3.09975813 |
| 28 | behavioral response to ethanol (GO:0048149) | 3.09801050 |
| 29 | cilium or flagellum-dependent cell motility (GO:0001539) | 3.09774366 |
| 30 | regulation of hippo signaling (GO:0035330) | 3.06949829 |
| 31 | nephron tubule morphogenesis (GO:0072078) | 3.03230895 |
| 32 | nephron epithelium morphogenesis (GO:0072088) | 3.03230895 |
| 33 | transmission of nerve impulse (GO:0019226) | 3.02074651 |
| 34 | ketone body metabolic process (GO:1902224) | 3.01275421 |
| 35 | signal peptide processing (GO:0006465) | 3.00490593 |
| 36 | membrane depolarization during action potential (GO:0086010) | 2.96655751 |
| 37 | regulation of action potential (GO:0098900) | 2.95406351 |
| 38 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.91580576 |
| 39 | reflex (GO:0060004) | 2.90732102 |
| 40 | head development (GO:0060322) | 2.90075160 |
| 41 | neuronal action potential (GO:0019228) | 2.88951154 |
| 42 | oxidative demethylation (GO:0070989) | 2.87656067 |
| 43 | axon ensheathment in central nervous system (GO:0032291) | 2.86902234 |
| 44 | central nervous system myelination (GO:0022010) | 2.86902234 |
| 45 | cornea development in camera-type eye (GO:0061303) | 2.83600631 |
| 46 | synaptic transmission, cholinergic (GO:0007271) | 2.80678290 |
| 47 | photoreceptor cell maintenance (GO:0045494) | 2.80614021 |
| 48 | sulfation (GO:0051923) | 2.78596514 |
| 49 | negative regulation of mast cell activation (GO:0033004) | 2.74487618 |
| 50 | protein import into peroxisome matrix (GO:0016558) | 2.73965204 |
| 51 | snRNA transcription (GO:0009301) | 2.72854356 |
| 52 | cardiovascular system development (GO:0072358) | 2.72803884 |
| 53 | negative regulation of sodium ion transport (GO:0010766) | 2.69045831 |
| 54 | rRNA catabolic process (GO:0016075) | 2.65528597 |
| 55 | negative regulation of systemic arterial blood pressure (GO:0003085) | 2.64953697 |
| 56 | primary amino compound metabolic process (GO:1901160) | 2.64338273 |
| 57 | epithelial cilium movement (GO:0003351) | 2.63304555 |
| 58 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.62948381 |
| 59 | kidney morphogenesis (GO:0060993) | 2.62301342 |
| 60 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.60928253 |
| 61 | response to pheromone (GO:0019236) | 2.59685732 |
| 62 | startle response (GO:0001964) | 2.59348840 |
| 63 | aromatic amino acid family catabolic process (GO:0009074) | 2.59118025 |
| 64 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:004316 | 2.58731901 |
| 65 | neuronal action potential propagation (GO:0019227) | 2.58611086 |
| 66 | regulation of sarcomere organization (GO:0060297) | 2.58600109 |
| 67 | spinal cord motor neuron differentiation (GO:0021522) | 2.58075885 |
| 68 | serotonin metabolic process (GO:0042428) | 2.56646523 |
| 69 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 2.55953414 |
| 70 | regulation of translation, ncRNA-mediated (GO:0045974) | 2.55953414 |
| 71 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 2.55953414 |
| 72 | positive regulation of CREB transcription factor activity (GO:0032793) | 2.55856569 |
| 73 | cilium organization (GO:0044782) | 2.55850953 |
| 74 | cell differentiation in spinal cord (GO:0021515) | 2.55620559 |
| 75 | reciprocal DNA recombination (GO:0035825) | 2.55260082 |
| 76 | reciprocal meiotic recombination (GO:0007131) | 2.55260082 |
| 77 | cilium morphogenesis (GO:0060271) | 2.54337404 |
| 78 | endoderm formation (GO:0001706) | 2.52856229 |
| 79 | cilium movement (GO:0003341) | 2.52650367 |
| 80 | axoneme assembly (GO:0035082) | 2.52460789 |
| 81 | cell proliferation in forebrain (GO:0021846) | 2.52085372 |
| 82 | cilium assembly (GO:0042384) | 2.51022102 |
| 83 | positive regulation of sodium ion transmembrane transporter activity (GO:2000651) | 2.50324810 |
| 84 | dendritic spine morphogenesis (GO:0060997) | 2.50039307 |
| 85 | cAMP catabolic process (GO:0006198) | 2.49021992 |
| 86 | protein localization to cilium (GO:0061512) | 2.47685719 |
| 87 | photoreceptor cell development (GO:0042461) | 2.46468879 |
| 88 | NAD biosynthetic process (GO:0009435) | 2.45126653 |
| 89 | positive regulation of sodium ion transmembrane transport (GO:1902307) | 2.45096514 |
| 90 | detection of mechanical stimulus involved in sensory perception (GO:0050974) | 2.44918415 |
| 91 | auditory receptor cell stereocilium organization (GO:0060088) | 2.44486083 |
| 92 | tachykinin receptor signaling pathway (GO:0007217) | 2.44352028 |
| 93 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 2.43811306 |
| 94 | benzene-containing compound metabolic process (GO:0042537) | 2.42963479 |
| 95 | proline transport (GO:0015824) | 2.41943559 |
| 96 | protein polyglutamylation (GO:0018095) | 2.41796288 |
| 97 | limb development (GO:0060173) | 2.41785427 |
| 98 | appendage development (GO:0048736) | 2.41785427 |
| 99 | positive regulation of developmental pigmentation (GO:0048087) | 2.41723718 |
| 100 | negative regulation of multicellular organism growth (GO:0040015) | 2.41132547 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.16713493 |
| 2 | ZNF274_21170338_ChIP-Seq_K562_Hela | 3.31989120 |
| 3 | VDR_22108803_ChIP-Seq_LS180_Human | 3.22824998 |
| 4 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.09133681 |
| 5 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.65891795 |
| 6 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.55951006 |
| 7 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.43605733 |
| 8 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.28006174 |
| 9 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.16728481 |
| 10 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 2.03424649 |
| 11 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.00644384 |
| 12 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.89448209 |
| 13 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.85696524 |
| 14 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.82705641 |
| 15 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.77528818 |
| 16 | P300_19829295_ChIP-Seq_ESCs_Human | 1.77308900 |
| 17 | EWS_26573619_Chip-Seq_HEK293_Human | 1.76373674 |
| 18 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.75279135 |
| 19 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.73922198 |
| 20 | STAT3_23295773_ChIP-Seq_U87_Human | 1.68164096 |
| 21 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.67193857 |
| 22 | FUS_26573619_Chip-Seq_HEK293_Human | 1.66798862 |
| 23 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.64765288 |
| 24 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.62213162 |
| 25 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.62213162 |
| 26 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.61686208 |
| 27 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.60960040 |
| 28 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.60953925 |
| 29 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.60093455 |
| 30 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.60076434 |
| 31 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.59841632 |
| 32 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.57023878 |
| 33 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.56513973 |
| 34 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.56040986 |
| 35 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.53720999 |
| 36 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.51889135 |
| 37 | TCF4_23295773_ChIP-Seq_U87_Human | 1.50202234 |
| 38 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.50000391 |
| 39 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.49994048 |
| 40 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.49223144 |
| 41 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.48306342 |
| 42 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.45239091 |
| 43 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.44496950 |
| 44 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.43073716 |
| 45 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.42912722 |
| 46 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.42218398 |
| 47 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.39947420 |
| 48 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.39419051 |
| 49 | AR_25329375_ChIP-Seq_VCAP_Human | 1.37738134 |
| 50 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.37626503 |
| 51 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.35284646 |
| 52 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.34772144 |
| 53 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.34772144 |
| 54 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.34507858 |
| 55 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.32210501 |
| 56 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.30520828 |
| 57 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.30205020 |
| 58 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.29471272 |
| 59 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.28785491 |
| 60 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.27313038 |
| 61 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.26406944 |
| 62 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.25890302 |
| 63 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.23051660 |
| 64 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.21856161 |
| 65 | * TP53_22573176_ChIP-Seq_HFKS_Human | 1.21471202 |
| 66 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.21290194 |
| 67 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.18882226 |
| 68 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.17973208 |
| 69 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.17722111 |
| 70 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.17406380 |
| 71 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.16649511 |
| 72 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.15794189 |
| 73 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.14675325 |
| 74 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.13232133 |
| 75 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.13106386 |
| 76 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.13106386 |
| 77 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.11719561 |
| 78 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.10729157 |
| 79 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.10512209 |
| 80 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.10458324 |
| 81 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.10458324 |
| 82 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.10025304 |
| 83 | NCOR_22424771_ChIP-Seq_293T_Human | 1.09144979 |
| 84 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 1.04721421 |
| 85 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.04574671 |
| 86 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.04495176 |
| 87 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.03930599 |
| 88 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.03930599 |
| 89 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.02208285 |
| 90 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.02200969 |
| 91 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.01664487 |
| 92 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.99346362 |
| 93 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.98683533 |
| 94 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 0.98670234 |
| 95 | TP53_16413492_ChIP-PET_HCT116_Human | 0.98230516 |
| 96 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.97093396 |
| 97 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.96634103 |
| 98 | ERA_21632823_ChIP-Seq_H3396_Human | 0.96452455 |
| 99 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.96292792 |
| 100 | RXR_22108803_ChIP-Seq_LS180_Human | 0.95647124 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003646_muscle_fatigue | 2.64586265 |
| 2 | MP0000569_abnormal_digit_pigmentation | 2.59815521 |
| 3 | MP0005551_abnormal_eye_electrophysiolog | 2.51519062 |
| 4 | MP0003136_yellow_coat_color | 2.47905957 |
| 5 | MP0009046_muscle_twitch | 2.45182860 |
| 6 | MP0003195_calcinosis | 2.42707061 |
| 7 | MP0001968_abnormal_touch/_nociception | 2.39048085 |
| 8 | MP0006276_abnormal_autonomic_nervous | 2.35889863 |
| 9 | MP0002837_dystrophic_cardiac_calcinosis | 2.34118257 |
| 10 | MP0006292_abnormal_olfactory_placode | 2.26589831 |
| 11 | MP0009745_abnormal_behavioral_response | 2.17311530 |
| 12 | MP0003787_abnormal_imprinting | 2.16725862 |
| 13 | MP0005423_abnormal_somatic_nervous | 2.09758621 |
| 14 | MP0002638_abnormal_pupillary_reflex | 2.04050344 |
| 15 | MP0008877_abnormal_DNA_methylation | 2.03050979 |
| 16 | MP0004142_abnormal_muscle_tone | 2.00396664 |
| 17 | MP0002653_abnormal_ependyma_morphology | 1.97841989 |
| 18 | MP0001986_abnormal_taste_sensitivity | 1.94846758 |
| 19 | MP0002272_abnormal_nervous_system | 1.93314815 |
| 20 | MP0001485_abnormal_pinna_reflex | 1.90871088 |
| 21 | MP0004043_abnormal_pH_regulation | 1.90320974 |
| 22 | MP0004885_abnormal_endolymph | 1.89716809 |
| 23 | MP0002736_abnormal_nociception_after | 1.82296220 |
| 24 | MP0001501_abnormal_sleep_pattern | 1.81274393 |
| 25 | MP0002102_abnormal_ear_morphology | 1.80889851 |
| 26 | MP0003880_abnormal_central_pattern | 1.80092128 |
| 27 | MP0003890_abnormal_embryonic-extraembry | 1.77594536 |
| 28 | MP0000427_abnormal_hair_cycle | 1.76685820 |
| 29 | MP0002572_abnormal_emotion/affect_behav | 1.74641229 |
| 30 | MP0004145_abnormal_muscle_electrophysio | 1.70717713 |
| 31 | MP0008872_abnormal_physiological_respon | 1.69511025 |
| 32 | MP0003635_abnormal_synaptic_transmissio | 1.63628579 |
| 33 | MP0002557_abnormal_social/conspecific_i | 1.63168367 |
| 34 | MP0004147_increased_porphyrin_level | 1.60437147 |
| 35 | MP0002064_seizures | 1.57925183 |
| 36 | MP0001486_abnormal_startle_reflex | 1.56448601 |
| 37 | MP0002733_abnormal_thermal_nociception | 1.56306808 |
| 38 | MP0002063_abnormal_learning/memory/cond | 1.56087450 |
| 39 | MP0002735_abnormal_chemical_nociception | 1.55665561 |
| 40 | MP0001970_abnormal_pain_threshold | 1.54719423 |
| 41 | MP0000778_abnormal_nervous_system | 1.47488143 |
| 42 | MP0004133_heterotaxia | 1.46704186 |
| 43 | MP0002876_abnormal_thyroid_physiology | 1.45835850 |
| 44 | MP0004924_abnormal_behavior | 1.45385060 |
| 45 | MP0005386_behavior/neurological_phenoty | 1.45385060 |
| 46 | MP0002938_white_spotting | 1.45336293 |
| 47 | MP0004130_abnormal_muscle_cell | 1.43696109 |
| 48 | MP0005645_abnormal_hypothalamus_physiol | 1.43613546 |
| 49 | MP0002067_abnormal_sensory_capabilities | 1.42453595 |
| 50 | MP0005646_abnormal_pituitary_gland | 1.40776561 |
| 51 | MP0005253_abnormal_eye_physiology | 1.39817922 |
| 52 | MP0004742_abnormal_vestibular_system | 1.39798550 |
| 53 | MP0000631_abnormal_neuroendocrine_gland | 1.39224902 |
| 54 | MP0006072_abnormal_retinal_apoptosis | 1.33926748 |
| 55 | MP0002928_abnormal_bile_duct | 1.28199047 |
| 56 | MP0005174_abnormal_tail_pigmentation | 1.26003203 |
| 57 | MP0005195_abnormal_posterior_eye | 1.23962649 |
| 58 | MP0005377_hearing/vestibular/ear_phenot | 1.23367666 |
| 59 | MP0003878_abnormal_ear_physiology | 1.23367666 |
| 60 | MP0008875_abnormal_xenobiotic_pharmacok | 1.19439804 |
| 61 | MP0003879_abnormal_hair_cell | 1.16741198 |
| 62 | MP0002734_abnormal_mechanical_nocicepti | 1.15238320 |
| 63 | MP0002752_abnormal_somatic_nervous | 1.14568968 |
| 64 | MP0002163_abnormal_gland_morphology | 1.13239163 |
| 65 | MP0000955_abnormal_spinal_cord | 1.13011787 |
| 66 | MP0002184_abnormal_innervation | 1.12816403 |
| 67 | MP0003252_abnormal_bile_duct | 1.10560881 |
| 68 | MP0002160_abnormal_reproductive_system | 1.10195225 |
| 69 | MP0000026_abnormal_inner_ear | 1.09889131 |
| 70 | MP0000230_abnormal_systemic_arterial | 1.09577767 |
| 71 | MP0003121_genomic_imprinting | 1.08800501 |
| 72 | MP0001963_abnormal_hearing_physiology | 1.07715571 |
| 73 | MP0010386_abnormal_urinary_bladder | 1.06587202 |
| 74 | MP0000372_irregular_coat_pigmentation | 1.04696954 |
| 75 | MP0002138_abnormal_hepatobiliary_system | 1.03976305 |
| 76 | MP0003122_maternal_imprinting | 1.03361622 |
| 77 | MP0002882_abnormal_neuron_morphology | 1.02781294 |
| 78 | MP0001440_abnormal_grooming_behavior | 1.02063755 |
| 79 | MP0004859_abnormal_synaptic_plasticity | 0.99699888 |
| 80 | MP0003119_abnormal_digestive_system | 0.99591902 |
| 81 | MP0003011_delayed_dark_adaptation | 0.98372674 |
| 82 | MP0002229_neurodegeneration | 0.97240473 |
| 83 | MP0001984_abnormal_olfaction | 0.96677288 |
| 84 | MP0002095_abnormal_skin_pigmentation | 0.94424627 |
| 85 | MP0003283_abnormal_digestive_organ | 0.93941455 |
| 86 | MP0005389_reproductive_system_phenotype | 0.91622531 |
| 87 | MP0001502_abnormal_circadian_rhythm | 0.90280757 |
| 88 | MP0000538_abnormal_urinary_bladder | 0.88830112 |
| 89 | MP0003137_abnormal_impulse_conducting | 0.88056130 |
| 90 | MP0005084_abnormal_gallbladder_morpholo | 0.87395948 |
| 91 | MP0000383_abnormal_hair_follicle | 0.85502503 |
| 92 | MP0001529_abnormal_vocalization | 0.82752340 |
| 93 | MP0001324_abnormal_eye_pigmentation | 0.82617191 |
| 94 | MP0005448_abnormal_energy_balance | 0.82337138 |
| 95 | MP0002234_abnormal_pharynx_morphology | 0.82336213 |
| 96 | MP0008775_abnormal_heart_ventricle | 0.76663959 |
| 97 | MP0005085_abnormal_gallbladder_physiolo | 0.74334325 |
| 98 | MP0001905_abnormal_dopamine_level | 0.73811486 |
| 99 | MP0002152_abnormal_brain_morphology | 0.72279555 |
| 100 | MP0003698_abnormal_male_reproductive | 0.72099609 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Genetic anticipation (HP:0003743) | 4.74675343 |
| 2 | Pancreatic cysts (HP:0001737) | 4.59718739 |
| 3 | Pancreatic fibrosis (HP:0100732) | 4.38119243 |
| 4 | Hyperventilation (HP:0002883) | 4.17312103 |
| 5 | Abnormality of midbrain morphology (HP:0002418) | 4.13740229 |
| 6 | Molar tooth sign on MRI (HP:0002419) | 4.13740229 |
| 7 | Progressive cerebellar ataxia (HP:0002073) | 4.10095866 |
| 8 | True hermaphroditism (HP:0010459) | 4.10059773 |
| 9 | Congenital stationary night blindness (HP:0007642) | 3.94569775 |
| 10 | Nephronophthisis (HP:0000090) | 3.80422205 |
| 11 | Abnormality of the renal medulla (HP:0100957) | 3.30082498 |
| 12 | Protruding tongue (HP:0010808) | 3.27873103 |
| 13 | Cystic liver disease (HP:0006706) | 3.25146445 |
| 14 | Abnormality of the renal cortex (HP:0011035) | 3.18313507 |
| 15 | Chronic hepatic failure (HP:0100626) | 3.12943299 |
| 16 | Attenuation of retinal blood vessels (HP:0007843) | 3.11616277 |
| 17 | Medial flaring of the eyebrow (HP:0010747) | 3.09124229 |
| 18 | Gaze-evoked nystagmus (HP:0000640) | 2.99531029 |
| 19 | Tubular atrophy (HP:0000092) | 2.91734938 |
| 20 | Type II lissencephaly (HP:0007260) | 2.89327902 |
| 21 | Clumsiness (HP:0002312) | 2.71557656 |
| 22 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.71214177 |
| 23 | Pendular nystagmus (HP:0012043) | 2.70141547 |
| 24 | Gait imbalance (HP:0002141) | 2.67105864 |
| 25 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.65335396 |
| 26 | Abnormality of alanine metabolism (HP:0010916) | 2.65335396 |
| 27 | Hyperalaninemia (HP:0003348) | 2.65335396 |
| 28 | Sclerocornea (HP:0000647) | 2.63550574 |
| 29 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.63079112 |
| 30 | Abolished electroretinogram (ERG) (HP:0000550) | 2.60596905 |
| 31 | Inability to walk (HP:0002540) | 2.59729440 |
| 32 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.59396425 |
| 33 | Polydipsia (HP:0001959) | 2.59066710 |
| 34 | Abnormal drinking behavior (HP:0030082) | 2.59066710 |
| 35 | Decreased circulating renin level (HP:0003351) | 2.49119592 |
| 36 | Congenital primary aphakia (HP:0007707) | 2.48777271 |
| 37 | Broad-based gait (HP:0002136) | 2.46325345 |
| 38 | Decreased central vision (HP:0007663) | 2.46257847 |
| 39 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.44390303 |
| 40 | Cerebellar dysplasia (HP:0007033) | 2.38686588 |
| 41 | Febrile seizures (HP:0002373) | 2.38531192 |
| 42 | Absent/shortened dynein arms (HP:0200106) | 2.37615017 |
| 43 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.37615017 |
| 44 | Nephrogenic diabetes insipidus (HP:0009806) | 2.34361141 |
| 45 | Anencephaly (HP:0002323) | 2.34328075 |
| 46 | Keratoconus (HP:0000563) | 2.33598485 |
| 47 | Increased corneal curvature (HP:0100692) | 2.33598485 |
| 48 | Congenital hepatic fibrosis (HP:0002612) | 2.32670612 |
| 49 | Focal seizures (HP:0007359) | 2.32480078 |
| 50 | Lissencephaly (HP:0001339) | 2.30956222 |
| 51 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 2.30798477 |
| 52 | Patellar aplasia (HP:0006443) | 2.29947560 |
| 53 | Furrowed tongue (HP:0000221) | 2.28931282 |
| 54 | Large for gestational age (HP:0001520) | 2.27554468 |
| 55 | Aplasia/Hypoplasia of the patella (HP:0006498) | 2.17869291 |
| 56 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.17682284 |
| 57 | Agitation (HP:0000713) | 2.13533531 |
| 58 | Progressive inability to walk (HP:0002505) | 2.12583700 |
| 59 | Genital tract atresia (HP:0001827) | 2.04770383 |
| 60 | Vaginal atresia (HP:0000148) | 2.04706118 |
| 61 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.04409502 |
| 62 | Pachygyria (HP:0001302) | 2.03728034 |
| 63 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.03646224 |
| 64 | Renal cortical cysts (HP:0000803) | 2.03526410 |
| 65 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 2.01244160 |
| 66 | Birth length less than 3rd percentile (HP:0003561) | 1.98616144 |
| 67 | Postaxial foot polydactyly (HP:0001830) | 1.97946195 |
| 68 | Dialeptic seizures (HP:0011146) | 1.96363978 |
| 69 | Polyuria (HP:0000103) | 1.95118740 |
| 70 | Hypoplasia of the pons (HP:0012110) | 1.93940506 |
| 71 | Fair hair (HP:0002286) | 1.93580858 |
| 72 | Poor coordination (HP:0002370) | 1.91923522 |
| 73 | Male pseudohermaphroditism (HP:0000037) | 1.91844366 |
| 74 | Optic nerve hypoplasia (HP:0000609) | 1.89693764 |
| 75 | Abnormal ciliary motility (HP:0012262) | 1.89596989 |
| 76 | Bile duct proliferation (HP:0001408) | 1.89580018 |
| 77 | Abnormal biliary tract physiology (HP:0012439) | 1.89580018 |
| 78 | Abnormality of the pons (HP:0007361) | 1.88542771 |
| 79 | Congenital sensorineural hearing impairment (HP:0008527) | 1.88152230 |
| 80 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.86567149 |
| 81 | Retinitis pigmentosa (HP:0000510) | 1.85204763 |
| 82 | Rib fusion (HP:0000902) | 1.84410114 |
| 83 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.83776463 |
| 84 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.83776463 |
| 85 | Focal motor seizures (HP:0011153) | 1.81706502 |
| 86 | Chorioretinal atrophy (HP:0000533) | 1.81538537 |
| 87 | Abnormality of the renal collecting system (HP:0004742) | 1.81474589 |
| 88 | Polyphagia (HP:0002591) | 1.79853069 |
| 89 | Severe muscular hypotonia (HP:0006829) | 1.79183528 |
| 90 | Concave nail (HP:0001598) | 1.78280979 |
| 91 | Tachypnea (HP:0002789) | 1.78040888 |
| 92 | Absent speech (HP:0001344) | 1.77373683 |
| 93 | Congenital, generalized hypertrichosis (HP:0004540) | 1.75292250 |
| 94 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.73830274 |
| 95 | Hypoplasia of the fovea (HP:0007750) | 1.73830274 |
| 96 | Short foot (HP:0001773) | 1.72773388 |
| 97 | Dandy-Walker malformation (HP:0001305) | 1.71945481 |
| 98 | Bulbous nose (HP:0000414) | 1.71823842 |
| 99 | Abnormal pancreas size (HP:0012094) | 1.70167461 |
| 100 | Absence seizures (HP:0002121) | 1.69603779 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 7.68314165 |
| 2 | BMPR1B | 3.46452734 |
| 3 | ADRBK2 | 3.36587531 |
| 4 | ACVR1B | 3.29425911 |
| 5 | WNK4 | 3.07808460 |
| 6 | GRK1 | 2.40334358 |
| 7 | PINK1 | 2.16881158 |
| 8 | INSRR | 2.10521242 |
| 9 | CASK | 2.05065793 |
| 10 | TAOK3 | 1.95711657 |
| 11 | MAPK13 | 1.89121586 |
| 12 | ZAK | 1.81095702 |
| 13 | WNK3 | 1.79056788 |
| 14 | MAP3K4 | 1.77814572 |
| 15 | NTRK3 | 1.74607531 |
| 16 | TLK1 | 1.66741536 |
| 17 | STK39 | 1.58681862 |
| 18 | OXSR1 | 1.50804106 |
| 19 | MAP4K2 | 1.49616340 |
| 20 | NUAK1 | 1.49180131 |
| 21 | ADRBK1 | 1.48875787 |
| 22 | DAPK2 | 1.47734985 |
| 23 | MARK1 | 1.41923721 |
| 24 | NTRK2 | 1.32440749 |
| 25 | TGFBR1 | 1.31377678 |
| 26 | MKNK2 | 1.30268864 |
| 27 | SIK2 | 1.29676205 |
| 28 | PRKCG | 1.17333126 |
| 29 | MAP2K7 | 1.16822264 |
| 30 | CDK19 | 1.09127575 |
| 31 | PAK3 | 1.06232971 |
| 32 | PIK3CA | 1.03101556 |
| 33 | AKT3 | 0.99865193 |
| 34 | DYRK2 | 0.99254239 |
| 35 | CAMKK2 | 0.97354679 |
| 36 | STK11 | 0.97237434 |
| 37 | CAMK1D | 0.92522216 |
| 38 | TXK | 0.90532129 |
| 39 | TNIK | 0.83240131 |
| 40 | WNK1 | 0.80767778 |
| 41 | PRKCE | 0.79912818 |
| 42 | MUSK | 0.79288902 |
| 43 | MAPK15 | 0.77972966 |
| 44 | STK38L | 0.76266521 |
| 45 | SGK2 | 0.74055599 |
| 46 | STK3 | 0.73194267 |
| 47 | CAMK1 | 0.72986141 |
| 48 | MAP2K6 | 0.72690690 |
| 49 | PKN1 | 0.70942004 |
| 50 | TIE1 | 0.69234708 |
| 51 | PRKCH | 0.68428503 |
| 52 | SGK223 | 0.68181538 |
| 53 | SGK494 | 0.68181538 |
| 54 | NEK2 | 0.65184212 |
| 55 | CAMK1G | 0.64365602 |
| 56 | CAMKK1 | 0.64016945 |
| 57 | TNK2 | 0.63611251 |
| 58 | MAP2K4 | 0.61200610 |
| 59 | CAMK2A | 0.60454665 |
| 60 | TYRO3 | 0.60282538 |
| 61 | PRKAA2 | 0.58709251 |
| 62 | OBSCN | 0.55820253 |
| 63 | ERBB2 | 0.55752759 |
| 64 | PRKCQ | 0.55043370 |
| 65 | FGFR2 | 0.53541083 |
| 66 | PRKAA1 | 0.53325623 |
| 67 | TEC | 0.53130807 |
| 68 | MAP3K7 | 0.52734514 |
| 69 | PRKACA | 0.52224447 |
| 70 | PHKG2 | 0.51588034 |
| 71 | PHKG1 | 0.51588034 |
| 72 | PTK2B | 0.50108056 |
| 73 | RPS6KA6 | 0.48795246 |
| 74 | PNCK | 0.48648111 |
| 75 | MAPKAPK3 | 0.48589959 |
| 76 | CAMK4 | 0.47055439 |
| 77 | PRKCZ | 0.44479678 |
| 78 | MAPKAPK5 | 0.44248752 |
| 79 | EPHA4 | 0.41342037 |
| 80 | MARK3 | 0.40968513 |
| 81 | PRKCA | 0.38175710 |
| 82 | CSNK1A1 | 0.37446275 |
| 83 | SGK1 | 0.36729103 |
| 84 | ITK | 0.35942169 |
| 85 | PRKCI | 0.33747875 |
| 86 | CSNK1A1L | 0.32230535 |
| 87 | GRK7 | 0.31702689 |
| 88 | IKBKB | 0.30314568 |
| 89 | CSNK1G2 | 0.30002586 |
| 90 | DYRK1A | 0.29991052 |
| 91 | PIK3CG | 0.29380711 |
| 92 | CHUK | 0.29262785 |
| 93 | TRPM7 | 0.28839888 |
| 94 | BRSK2 | 0.28799992 |
| 95 | PLK2 | 0.28678024 |
| 96 | MAP2K1 | 0.28676176 |
| 97 | BCKDK | 0.28667055 |
| 98 | CSNK1D | 0.28594021 |
| 99 | MKNK1 | 0.28303500 |
| 100 | CDK5 | 0.28037865 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 2.92156551 |
| 2 | Phototransduction_Homo sapiens_hsa04744 | 2.91452039 |
| 3 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.55162778 |
| 4 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.48337737 |
| 5 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 2.47229567 |
| 6 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.23955745 |
| 7 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 2.19661953 |
| 8 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.11664900 |
| 9 | Morphine addiction_Homo sapiens_hsa05032 | 2.10945239 |
| 10 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 2.08531052 |
| 11 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 2.04510561 |
| 12 | Taste transduction_Homo sapiens_hsa04742 | 2.02240515 |
| 13 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.96517737 |
| 14 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.95566567 |
| 15 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.93097349 |
| 16 | ABC transporters_Homo sapiens_hsa02010 | 1.91611687 |
| 17 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.91018306 |
| 18 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.72021536 |
| 19 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.71729512 |
| 20 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.70410410 |
| 21 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.67981527 |
| 22 | Olfactory transduction_Homo sapiens_hsa04740 | 1.66987448 |
| 23 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.66469218 |
| 24 | GABAergic synapse_Homo sapiens_hsa04727 | 1.60239523 |
| 25 | Circadian entrainment_Homo sapiens_hsa04713 | 1.58850474 |
| 26 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.54759910 |
| 27 | Homologous recombination_Homo sapiens_hsa03440 | 1.53349611 |
| 28 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.51358647 |
| 29 | Insulin secretion_Homo sapiens_hsa04911 | 1.46859629 |
| 30 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.46058216 |
| 31 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.43836593 |
| 32 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.33200000 |
| 33 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.32608601 |
| 34 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.23064443 |
| 35 | Salivary secretion_Homo sapiens_hsa04970 | 1.13744872 |
| 36 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.13582399 |
| 37 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.12684525 |
| 38 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.12356197 |
| 39 | Long-term depression_Homo sapiens_hsa04730 | 1.11862204 |
| 40 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.11512923 |
| 41 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.11176827 |
| 42 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.11102729 |
| 43 | Retinol metabolism_Homo sapiens_hsa00830 | 1.10688953 |
| 44 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.08537516 |
| 45 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.08059068 |
| 46 | Basal transcription factors_Homo sapiens_hsa03022 | 1.04732169 |
| 47 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.03515821 |
| 48 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.02231314 |
| 49 | Peroxisome_Homo sapiens_hsa04146 | 0.97299562 |
| 50 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.94840507 |
| 51 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.94005928 |
| 52 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.93496413 |
| 53 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.92770089 |
| 54 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.90266528 |
| 55 | Histidine metabolism_Homo sapiens_hsa00340 | 0.87168142 |
| 56 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.84680921 |
| 57 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.83082499 |
| 58 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.83021061 |
| 59 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.79767627 |
| 60 | Sulfur relay system_Homo sapiens_hsa04122 | 0.78555318 |
| 61 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.76282380 |
| 62 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.74670788 |
| 63 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.72387403 |
| 64 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.72248189 |
| 65 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.72058931 |
| 66 | Cocaine addiction_Homo sapiens_hsa05030 | 0.69869453 |
| 67 | RNA polymerase_Homo sapiens_hsa03020 | 0.67187938 |
| 68 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.66462020 |
| 69 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.61687515 |
| 70 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.60803965 |
| 71 | RNA degradation_Homo sapiens_hsa03018 | 0.58377419 |
| 72 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.58288570 |
| 73 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.56406160 |
| 74 | Axon guidance_Homo sapiens_hsa04360 | 0.54943372 |
| 75 | Parkinsons disease_Homo sapiens_hsa05012 | 0.53990690 |
| 76 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.51447147 |
| 77 | Huntingtons disease_Homo sapiens_hsa05016 | 0.51415533 |
| 78 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.50381191 |
| 79 | Renin secretion_Homo sapiens_hsa04924 | 0.50199104 |
| 80 | Bile secretion_Homo sapiens_hsa04976 | 0.49701580 |
| 81 | Lysine degradation_Homo sapiens_hsa00310 | 0.47777456 |
| 82 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.45675676 |
| 83 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.45308315 |
| 84 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.43016737 |
| 85 | Alzheimers disease_Homo sapiens_hsa05010 | 0.42228643 |
| 86 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.41721601 |
| 87 | Mineral absorption_Homo sapiens_hsa04978 | 0.38665350 |
| 88 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.37825185 |
| 89 | Metabolic pathways_Homo sapiens_hsa01100 | 0.37257500 |
| 90 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.37128528 |
| 91 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.35224528 |
| 92 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.35054590 |
| 93 | Asthma_Homo sapiens_hsa05310 | 0.34027893 |
| 94 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.33091885 |
| 95 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.32799580 |
| 96 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.32319143 |
| 97 | Circadian rhythm_Homo sapiens_hsa04710 | 0.32111813 |
| 98 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.31429215 |
| 99 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.31242507 |
| 100 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.31060681 |

